Insulin aspart, recombinant Subcutaneous and Larotrectinib Oral Solution
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Larotrectinib Oral Solution and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Larotrectinib Sulfate
- Insulin aspart, recombinant Subcutaneous-Lartruvo
- Insulin aspart, recombinant Subcutaneous-Larynex
- Insulin aspart, recombinant Subcutaneous-Laryng-O-Jet
- Insulin aspart, recombinant Subcutaneous-Laryngesic
- Insulin aspart, recombinant Subcutaneous-Lasix
- Larotrectinib Oral Solution-Insulin degludec
- Larotrectinib Oral Solution-Insulin Degludec (U-100) Prefilled Pens
- Larotrectinib Oral Solution-Insulin Degludec (U-100) Vials
- Larotrectinib Oral Solution-Insulin Degludec (U-200) Prefilled Pens
- Larotrectinib Oral Solution-Insulin degludec and liraglutide
- Larotrectinib Oral Solution-Insulin degludec and liraglutide Subcutaneous